Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Chunky bootmaker Dr. Martens to sell shares to public

The maker of Dr. Martens boots, the chunky-soled footwear favored by celebrities like Rihanna and Kristen Stewart, plans to sell shares to the public as the existing owners seek to profit from growth of the iconic brand

Via AP news wire
Monday 11 January 2021 14:22 GMT
Britain Dr Martens
Britain Dr Martens (Copyright 2021 The Associated Press. All rights reserved.)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

The maker of Dr. Martens boots, the chunky-soled footwear once championed by rebellious young people but now favored by celebrities like Rihanna, plans to sell shares to the public as the existing owners seek to profit from growth of the iconic brand.

Dr. Martens Ltd. said Monday that current investors plan to sell at least 25% of their stake in an initial public offering on the London Stock Exchange.

Permira Funds, a London-based private equity investor, bought Dr. Martens for 300 million pounds (currently worth $400 million) in 2014. Private equity firms seek to buy undervalued companies then restructure their operations and cut costs before selling at a profit.

Dr. Martens Chief Executive Kenny Wilson said the IPO underscored the brand’s “global growth potential” after revenue increased by 39% over the past two financial years to an annual 672.2 million pounds ($900 million). The company is expanding online sales to complement revenue from 130 shops in 60 countries.

“Our iconic brand appeals to a diverse range of consumers around the world who wear our footwear to express their individual style,’’ Wilson said in a statement to the stock exchange. “We have invested massively to ensure that we deliver the best digital and store experiences to connect with our wearers.”

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in